Table 1.

Summary of Random-Effects Categorical Analysis Results for the Prevalence of ASD Diagnoses in GD/GI Individuals

Moderators	Q	df	p	Tau2	k	Prevalence	95% CI	p
Participants	7.80	2	0.020	0.79
Gender-referred					9	0.09	0.05, 0.15	< 0.001
Diagnosis/Criteria					7	0.07	0.03, 0.13	< 0.001
GI					9	0.20	0.12, 0.31	< 0.001
Study design	5.99	1	0.014	0.95
Clinical					15	0.08	0.05, 0.13	< 0.001
Population					9	0.20	0.12, 0.33	< 0.001

Note. Study codes are presented in Table S3. Gender-referred = participants referred to gender identity clinics/services; Diagnosis/Criteria = participants who met diagnostic criteria or had a diagnosis of GD, GID, or GID-NOS; GI = gender incongruent participants; Q = heterogeneity test; df = degrees of freedom; Tau² = pooled variance component; k = number of studies included in each group; prevalence = event rate of ASD diagnoses; 95% CI = 95% confidence intervals.